NRG Therapeutics’ £16 Million Series A Fundraising

Mills & Reeve advised NRG Therapeutics on the deal.The Stevenage-based life sciences company, founded in 2018, focuses on therapeutic approaches that will restore mitochondrial function and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here